<DOC>
	<DOCNO>NCT00190593</DOCNO>
	<brief_summary>The purpose study determine whether raloxifene compare placebo lower risk coronary event reduces risk invasive breast cancer postmenopausal woman risk major coronary event .</brief_summary>
	<brief_title>Raloxifene Use The Heart</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Postmenopausal woman establish coronary heart disease risk major coronary event . Postmenopausal symptom require estrogen replacement therapy . Suspected known history breast endometrial carcinoma . Known probable history deep venous thrombosis , pulmonary embolism , retinal vein thrombosis . New York Heart Association class III IV heart failure .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>